Cite

HARVARD Citation

    Mancini, M. et al. (2022). Knockout of NRF2 triggers prostate cancer cells death through ROS modulation and sensitizes to cisplatin. Journal of cellular biochemistry. 123 (12), pp. 2079-2092. [Online]. 
  
Back to record